These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14712216)

  • 41. Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.
    Drosten M; Hilken G; Böckmann M; Rödicker F; Mise N; Cranston AN; Dahmen U; Ponder BA; Pützer BM
    J Natl Cancer Inst; 2004 Aug; 96(16):1231-9. PubMed ID: 15316058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.
    Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A
    Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma.
    Basolo F; Giannini R; Monaco C; Melillo RM; Carlomagno F; Pancrazi M; Salvatore G; Chiappetta G; Pacini F; Elisei R; Miccoli P; Pinchera A; Fusco A; Santoro M
    Am J Pathol; 2002 Jan; 160(1):247-54. PubMed ID: 11786418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.
    Rabes HM; Demidchik EP; Sidorow JD; Lengfelder E; Beimfohr C; Hoelzel D; Klugbauer S
    Clin Cancer Res; 2000 Mar; 6(3):1093-103. PubMed ID: 10741739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5.
    Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
    Cancer Res; 1998 Jan; 58(2):198-203. PubMed ID: 9443391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia.
    Chua EL; Wu WM; Tran KT; McCarthy SW; Lauer CS; Dubourdieu D; Packham N; O'Brien CJ; Turtle JR; Dong Q
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2733-9. PubMed ID: 10946873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation.
    Bounacer A; Wicker R; Schlumberger M; Sarasin A; Suárez HG
    Biochimie; 1997 Oct; 79(9-10):619-23. PubMed ID: 9466701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene.
    Portella G; Salvatore D; Botti G; Cerrato A; Zhang L; Mineo A; Chiappetta G; Santelli G; Pozzi L; Vecchio G; Fusco A; Santoro M
    Oncogene; 1996 Nov; 13(9):2021-6. PubMed ID: 8934550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas.
    Cetta F; Chiappetta G; Melillo RM; Petracci M; Montalto G; Santoro M; Fusco A
    J Clin Endocrinol Metab; 1998 Mar; 83(3):1003-6. PubMed ID: 9506763
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of silencing RET/PTC1 junction oncogene in human papillary thyroid carcinoma cells.
    Gilbert-Sirieix M; Ripoche H; Malvy C; Massaad-Massade L
    Thyroid; 2010 Oct; 20(10):1053-65. PubMed ID: 20615140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
    Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N
    J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22).
    Schwaller J; Anastasiadou E; Cain D; Kutok J; Wojiski S; Williams IR; LaStarza R; Crescenzi B; Sternberg DW; Andreasson P; Schiavo R; Siena S; Mecucci C; Gilliland DG
    Blood; 2001 Jun; 97(12):3910-8. PubMed ID: 11389034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proto-RET is rearranged in the new human papillary thyroid cancer cell line PTC-1113A.
    Herrmann ME
    Cancer Genet Cytogenet; 1996 Jul; 89(1):14-20. PubMed ID: 8689603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma.
    Rhoden KJ; Johnson C; Brandao G; Howe JG; Smith BR; Tallini G
    Lab Invest; 2004 Dec; 84(12):1557-70. PubMed ID: 15502856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of down stream molecules of RET (p-ERK, p-p38 MAPK, p-JNK and p-AKT) in papillary thyroid carcinomas.
    Shin E; Hong SW; Kim SH; Yang WI
    Yonsei Med J; 2004 Apr; 45(2):306-13. PubMed ID: 15119004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer.
    Cheung CC; Carydis B; Ezzat S; Bedard YC; Asa SL
    J Clin Endocrinol Metab; 2001 May; 86(5):2187-90. PubMed ID: 11344225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells.
    Nikiforova MN; Stringer JR; Blough R; Medvedovic M; Fagin JA; Nikiforov YE
    Science; 2000 Oct; 290(5489):138-41. PubMed ID: 11021799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RET oncogene activation in papillary thyroid carcinoma.
    Tallini G; Asa SL
    Adv Anat Pathol; 2001 Nov; 8(6):345-54. PubMed ID: 11707626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different significance of ret/PTC(1) and ret/PTC(3) rearrangements in thyroid carcinogenesis: lesson from two subgroups of patients with papillary thyroid carcinomas showing the highest incidence of ret/PTC activation.
    Cetta F; Gori M; Montalto G; Zuckermann M; Toti P
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1429. PubMed ID: 11238550
    [No Abstract]   [Full Text] [Related]  

  • 60. The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus.
    Pisarchik AV; Ermak G; Fomicheva V; Kartel NA; Figge J
    Thyroid; 1998 Feb; 8(2):133-9. PubMed ID: 9510121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.